Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
41
AMRN Quote, Financials, Valuation and Earnings
Last price:
$11.80
Seasonality move
:
-4.06%
Day range:
$11.76 - $12.07
52-week range:
$7.08 - $16.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.14x
P/B ratio:
0.52x
Volume:
46.1K
Avg. volume:
75.5K
1-year change:
-15.39%
Market cap:
$245.3M
Revenue:
$228.6M
EPS (TTM):
-$4.33
Amarin Corp PLC Number of Institutional Trades
Amarin Corp PLC Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$575.8M
(Last 6 Months)
Current Institutional Ownership Percentage
17.82%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$1.8B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Amarin Corp PLC Institutional Ownership
-
What Percentage Of AMRN Is Owned by Institutions?
17.82% of AMRN is owned by institutions.
-
How Many Institutions Own AMRN Shares?
Amarin Corp PLC stock is owned by 205 institutional shareholders at this time.
-
Have Institutions Been Buying AMRN Stock?
Yes, institutions have bought 34M shares of AMRN in the last quarter.
-
Have Institutions Been Selling AMRN Stock?
Yes, institutions have sold 62.1M shares of AMRN over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
52
CTRN alert for Jun 5
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
